Topic: How To Invest

Q: Pat, can I get your recommendation on Teleflex? It looks like a good stock for the future. Thank you.

Article Excerpt

A: Teleflex Inc., $253.39, symbol TFX on New York (Shares outstanding: 47.0 million; Market cap: $12.0 billion; www.teleflex.com), is a global provider of medical technologies. Its apparatuses and other devices focus on several specialty areas, including vascular access, interventional cardiology and radiology, anaesthesia, emergency medicine, plus surgical, urologic and respiratory care. The company’s brands include Arrow, Deknatel, LMA, Pilling, QuikClot, Rusch, UroLift and Weck. On July 26, 2023, Teleflex acquired Palette Life Sciences for $600 million in upfront cash and an additional $50 million upon reaching certain milestones. The acquisition strengthens the company’s Interventional Urology portfolio. Palette’s principal product is Barrigel, a biodegradable sculptable rectal spacer. It’s expected to generate annual revenue of $56 million in 2023. (Used in radiotherapy, a rectal spacer pushes the rectum away from the prostate, and therefore away from high radiation doses. This can help reduce potential side effects.) Teleflex’s revenue rose 6.0% from $2.45 billion in 2018 to $2.60 billion in 2019. Revenue then fell by 2.2%…